Sarah Abou Alaiwi

11PUBLICATIONS
111CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular targetsCardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 24, 2026
Epigenetic Atlas of Bladder Cancer Reveals Master Transcription Factors and Risk-Associated Regulatory Elements in Luminal and Basal-Squamous Molecular Subtypes.

Elio Adib, Amin H Nassar, Sarah Abou Alaiwi

|Aug 08, 2024
MYBL2 Drives Prostate Cancer Plasticity: Inhibiting Its Transcriptional Target CDK2 for RB1-Deficient Neuroendocrine Prostate Cancer.

Beatriz German, Sarah A Alaiwi, Kun-Lin Ho

|Aug 23, 2023
A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus.

Sandor Spisak, Viktoria Tisza, Pier Vitale Nuzzo

|May 25, 2023
Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.

Sarah Abou Alaiwi, Thomas M Roston, Peter Marstrand

|Dec 16, 2022
Germline variants associated with toxicity to immune checkpoint blockade.

Stefan Groha, Sarah Abou Alaiwi, Wenxin Xu

|Dec 24, 2021
CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.

Elio Adib, Talal El Zarif, Amin H Nassar

Pageof 2

Frequent Collaborators

8 joint publications

Matthew L Freedman

6 joint publications

Amin Nassar

5 joint publications

Kate Lawrenson

4 joint publications

Alexander Gusev